Intrinsically disordered proteins have resisted structure-based drug discovery because they lack a stable fold to model. Talus Bio’s structure-free AI model sidesteps that limitation, targeting these proteins in their native environment instead of in isolation or from a predicted structure.
The post Talus Bio’s Structure-Free AI Model Targets Unstructured…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
